Home › NCT07586397

HIPS Feasibility Randomized Controlled Trial

HIPS Feasibility RCT Testing a Mind-Body Intervention to Improve Recovery for Individuals With Chronic Hip Pain

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Presenting with chronic (lasting ≥3 months) hip joint-related pain
2. Fluent in English
3. Age ≥18yr \[If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence \[KL\] grade 0-1)\]
4. Score ≥3 for current hip pain on the Pain-VAS
5. Psychological risk factor for the maintenance of pain by meeting ≥1 of the criteria listed below:

   1. Score ≥ 20 on the PCS
   2. Score ≤ 40 on the PSEQ
   3. Score ≥ 17 on the TSK-11
6. Exhibits sedentariness or dissatisfaction with physical activity by meeting ≥1 of the criteria listed below:

   1. Physically active \< 150mins/week according to the IPAQ-SF
   2. Hip pain interferes with the ability to be physically active
   3. Dissatisfaction with the current physical activity level

Exclusion Criteria:

1. Previous surgery on the symptomatic (painful) hip
2. Current pain referred from the lower back

About the study

The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.

What is being tested

• HIPS-1 (behavioral)
• HIPS-2 (behavioral)

Sponsor: Massachusetts General Hospital · Participants: 50 · Started: Jul 20, 2026

Contact the study team

• Kate Jochimsen, PhD, ATC · Phone: 920-948-7812

Official record on ClinicalTrials.gov — NCT07586397

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.